research

Autologous lymphokine-activated killer (LAK) cell therapy of EBV+ and EBV- lymphoproliferative disorders arising in organ transplant recipients

Authors
Publication date
1 January 1997
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    D-Scholarship@Pitt

    redirect
    oaioai:d-scholarship.pitt.edu:535...
    Last time updated on 19/07/2013